EA
ELV icon

Euclid Advisors’s Elevance Health ELV Stock Holding History

Euclid Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-24,923
Closed -$3.27M – 153
2016
Q2 		$3.27M Buy
24,923
+600
+2% +$82.1K 0.14% 217
2016
Q1 		$3.38M Sell
24,323
-35,512
-59% -$4.75M 0.13% 224
2015
Q4 		$8.34M Sell
59,835
-5,250
-8% -$723K 0.25% 138
2015
Q3 		$9.11M Sell
65,085
-20,030
-24% -$3.01M 0.41% 84
2015
Q2 		$14M Sell
85,115
-14,435
-15% -$2.31M 0.28% 115
2015
Q1 		$15.4M Buy
+99,550
New +$14.2M 0.28% 78
2014
Q4 		– Sell
-143,390
Closed -$17.2M – 408
2014
Q3 		$17.2M Buy
143,390
+6,110
+4% +$701K 0.12% 163
2014
Q2 		$14.8M Sell
137,280
-22,768
-14% -$2.35M 0.1% 198
2014
Q1 		$15.9M Buy
160,048
+37,250
+30% +$3.37M 0.12% 164
2013
Q4 		$11.3M Sell
122,798
-6,510
-5% -$578K 0.09% 217
2013
Q3 		$10.8M Buy
129,308
+26,339
+26% +$2.26M 0.11% 195
2013
Q2 		$8.43M Buy
+102,969
New +$7.71M 0.11% 222

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Euclid Advisors's ELV Position: Q3 2016 in Review

Euclid Advisors sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 24,923 shares — an estimated $3.27M sold.

Euclid Advisors first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $17.2M in Q3 2014. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Euclid Advisors reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 24,923 Elevance Health shares in Q3 2016, an estimated $3.27M.
  • Euclid Advisors first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
  • Euclid Advisors's Elevance Health position peaked at $17.2M in Q3 2014.
  • 737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.